Blue Jet Healthcare · NSE: BLUEJET · BSE: 544009
Q2 FY26 results · Jul–Sep 2025
Blue Jet Healthcare reported revenue from operations of ₹165.48 crore (down 20.5% from Q2 FY25) and net profit of ₹52.14 crore (down 10.6% from Q2 FY25) for Q2 FY26 (Jul–Sep 2025), on a standalone basis.
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 165.48 | 208.26 | −20.5% | 354.76 | −53.4% |
| Other income | 24.27 | 12.07 | +101.0% | 8.25 | +194.1% |
| Total income | 189.75 | 220.33 | −13.9% | 363.01 | −47.7% |
| Profit before tax | 68.73 | 76.92 | −10.7% | 122.86 | −44.1% |
| Net profit for the period | 52.14 | 58.35 | −10.6% | 91.17 | −42.8% |
| EPS, basic (₹) | 3.01 | 3.36 | −10.5% | 5.26 | −42.8% |
| Net margin (%) | 31.5 | 28.0 | 25.7 |
Standalone
- Filed with BSE
- 04 Nov 2025, 16:31 IST
- Board meeting
- 04 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE